PMND1: John Lieske, M.D.
John Lieske, M.D., describes Mayo Clinic Laboratories' new test for primary membranous nephropathy. PMND1 is a diagnostic cascade that provides cost-effective testing to determine the antigen that's causing the kidney disease.
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
(00:31)
Could you tell us a bit about yourself and your background?
(01:11)
Could you describe these new tests and when it would be appropriate to use each of them in the clinic?
(03:16)
Could you provide a little background on why MCL is making changes to the PLA2R test?
(04:34)
Could you describe the change to KDIGO guidelines and when it may be appropriate to skip the biopsy? How will these new tests help physicians implement these new guidelines in their practices?